Skip to main content
Premium Trial:

Request an Annual Quote

Bioo, Jungwoo Partner on Cancer MDx Technologies

NEW YORK (GenomeWeb News) – Bioo Scientific and Jungwoo F&B are partnering in an effort to improve methods of cancer diagnosis and treatment, the Austin, Texas-based company said on Monday.

As part of the collaboration Bioo will develop kits for use on Jungwoo's Image Oriented Navigation Laser Microdissection Device imaging platform. Bioo will also develop kits for global microRNA profiling and for protein extraction for peptide analysis of tumor samples using mass spectrometry.

The collaboration results from the UT Gyeonggi Innovation Program, a partnership between the University of Texas at Austin and the Gyeonggi Province in South Korea to identify promising technologies developed in the region for introduction into the US.

Jungwoo is a South Korean firm specializing in the development of systems and tools for industrial automation.

Financial and other terms of the deal were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.